🌱 KidneyEnergy.com

← brief for 2026-08-20 · Slowing decline

Cumulative C-reactive protein exposure links to COPD risk in adults with cardiovascular-kidney-metabolic syndrome stages 0-3 (no overt CVD): A prospective cohort study.

Article B Peer reviewed Small trial

Key takeaways

A study of 4887 patients with cardiovascular-kidney-metabolic (CKM) syndrome. It examines how inflammation biomarkers predict COPD risk in patients with kidney disease.

Who did this work

Liu Y · Gong J · Zhang J · Tan J · Tan C

Source

Article · PubMed, CKD severity and reversal · 2026 Aug 20
https://pubmed.ncbi.nlm.nih.gov/42622619/